Abstract
Arachidonic acid metabolites, the eicosanoids, are key mediators of allergen-induced airway inflammation and remodeling in asthma. The availability of free arachidonate in cells for subsequent eicosanoid biosynthesis is controlled by phospholipase A2s (PLA2s), most notably cytosolic PLA2-α. 10 secreted PLA2s (sPLA 2s) have also been identified, but their function in eicosanoid generation is poorly understood. We investigated the role of group X sPLA 2 (sPLA2-X), the sPLA2 with the highest in vitro cellular phospholipolysis activity, in acute and chronic mouse asthma models in vivo. The lungs of sPLA2-X?/? mice, compared with those of sPLA2-X+/+ littermates, had significant reduction in ovalbumin-induced infiltration by CD4+ and CD8 + T cells and eosinophils, goblet cell metaplasia, smooth muscle cell layer thickening, subepithelial fibrosis, and levels of T helper type 2 cell cytokines and eicosanoids. These data direct attention to sPLA2-X as a novel therapeutic target for asthma. JEM © The Rockefeller University Press.
Cite
CITATION STYLE
Henderson, W. R., Chi, E. Y., Bollinger, J. G., Tien, Y. T., Ye, X., Castelli, L., … Gelb, M. H. (2007). Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. Journal of Experimental Medicine, 204(4), 865–877. https://doi.org/10.1084/jem.20070029
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.